VT-1598

CAS No. 2089320-99-8

VT-1598( VT1598 )

Catalog No. M13269 CAS No. 2089320-99-8

VT-1598 is a potent, high-affinity, oral inhibitor of fungal sterol 14α-demethylase (CYP51B) with Kd of 13 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 284 Get Quote
50MG 1485 Get Quote
100MG 2385 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    VT-1598
  • Note
    Research use only, not for human use.
  • Brief Description
    VT-1598 is a potent, high-affinity, oral inhibitor of fungal sterol 14α-demethylase (CYP51B) with Kd of 13 nM.
  • Description
    VT-1598 is a potent, high-affinity, oral inhibitor of fungal sterol 14α-demethylase (CYP51B) with Kd of 13 nM; is more selective for fungal CYP51 than related human CYP enzymes such as CYP3A4; exhibits excellent potency against yeast, dermatophyte, and mold fungal pathogens.
  • In Vitro
    Cell Viability Assay Cell Line:100?C. auris isolatesConcentration:0.015-8?μg/mL Incubation Time:24 hours Result:Showed MICs ranging from 0.03 to 8?μg/ mL against all isolates, with MIC50 and MIC90 values of 0.25 and 1?μg/mL, respectively.Cell Viability Assay Cell Line:28 Candida isolates obtained from mucosal sites of APECED patients Concentration:0.03125-0.125?μg/mL Incubation Time:24 hours Result:Demonstrated potent in vitro activity against all 28 isolates (MIC range=0.03125-0.125?mg/L), with the MIC50 and MIC90 values of 0.0625 and 0.125?mg/L, respectively.
  • In Vivo
    Animal Model:Mice model of invasive candidiasis Dosage:5, 15, and 50?mg/kg Administration:Oral gavage; once daily; 7 daysResult:Observed median survival in the VT-1598 15 mg/kg and 50 mg/kg groups (15?days and >21?days, respectively) longer than the control group.Observed kidney fungal burden in mice treated with 15 mg/kg and 50 mg/kg doses (mean log10 CFU/g, 5.40 and 3.67, respectively) lower than the vehicle control group.Showed mean trough concentrations 1.55?μg/mL after 7?days of therapy in the 5 mg/kg group, 6.78?μg/mL in the 15 mg/kg group, and 14.2?μg/mL in the 50 mg/kg group.Animal Model:Act1-deficient mice infected with C. albicans Dosage:3.2, 8, and 20?mg/kg Administration:Oral gavage; once daily; 4 days Result:Resulted in high concentrations in the plasma and tongues of Candida-infected mice.
  • Synonyms
    VT1598
  • Pathway
    Microbiology/Virology
  • Target
    Fungal
  • Recptor
    Fungal
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    2089320-99-8
  • Formula Weight
    584.535
  • Molecular Formula
    C31H20F4N6O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (171.08 mM)
  • SMILES
    C1=CC(=CC=C1COC2=CC=C(C=C2)C#CC3=CN=C(C=C3)C(C(CN4C=NN=N4)(C5=C(C=C(C=C5)F)F)O)(F)F)C#N
  • Chemical Name
    (R)-4-((4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1H-tetrazol-1-yl)propyl)pyridin-3-yl)ethynyl)phenoxy)methyl)benzonitrile

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Hargrove TY, et al. Antimicrob Agents Chemother. 2017 Jun 27;61(7). pii: e00570-17. 2. Yates CM, et al. Bioorg Med Chem Lett. 2017 Aug 1;27(15):3243-3248. 3. Wiederhold NP, et al. J Antimicrob Chemother. 2018 Feb 1;73(2):404-408.
molnova catalog
related products
  • Griseofulvin

    A spirocyclic fungal natural product used in treatment of fungal dermatophytes.

  • Posaconazole hydrate

    A triazole antifungal agent that blocks the synthesis of ergosterol by inhibiting of the enzyme lanosterol 14α-demethylase and accumulation of methylated sterol precursors.

  • Posaconazole

    A triazole antifungal agent that blocks the synthesis of ergosterol by inhibiting of the enzyme lanosterol 14α-demethylase and accumulation of methylated sterol precursors.